Another work about the prognostic impact of GNAQ and GNA11 mutations was also published by Staby et al. in 2018, whom found no significant differences in the prevalence of GNAQ and GNA11 mutations between the patients with or without metastatic disease. The gene discussed is GNA11; the disease is metastatic neoplasm.